- Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)RecruitingNCT07428538Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution TrialRecruitingNCT07778888Phase 2
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2RecruitingNCT06997003Not applicable
Sponsor listed in the registry: Bausch & Lomb GmbH · First submitted after Bausch & Lomb GmbH became part of Bausch Health Companies Inc.
- Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative ColitisNot yet recruitingNCT05976802Phase 4
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive DisorderNot yet recruitingNCT02129751Phase 4
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute DiarrheaRecruitingNCT07285785Phase 4
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoRecruitingNCT07524946Phase 4
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract SurgeryRecruitingNCT06246136Not applicable
Sponsor listed in the registry: Elios Vision, Inc. · First submitted before Elios Vision, Inc. became part of Bausch Health Companies Inc.
- A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic AstigmatismNot yet recruitingNCT07377474Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- IC-8 Apthera IOL New Enrollment Post Approval StudyRecruitingNCT06060041
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe PsoriasisEnrolling by invitationNCT03254667
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative ColitisRecruitingNCT04314375Phase 4
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in ChildrenRecruitingNCT06305663Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive KeratectomyNot yet recruitingNCT06618547Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Post-Approval Study With the KAMRA InlayNot yet recruitingNCT03173664
Sponsor listed in the registry: AcuFocus, Inc. · First submitted before AcuFocus, Inc. became part of Bausch Health Companies Inc.
- Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisCompletedNCT05071716Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency TreatmentActive, not recruitingNCT07187297Not applicable
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin ResurfacingActive, not recruitingNCT07214272Not applicable
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FCActive, not recruitingNCT07723924Phase 2
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisCompletedNCT05297448Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive KeratectomyCompletedNCT07412496Phase 2
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Safety and Efficacy of IDP-118 in Participants With Plaque PsoriasisCompletedNCT02462122Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- The Plecanatide Irritable Bowel Syndrome With Constipation Safety and Efficacy Study (IBS-C)CompletedNCT02387359Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Participants With Acne VulgarisCompletedNCT03664752Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Participants With Acne VulgarisCompletedNCT02932306Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Safety and Efficacy of IDP-122 in Participants With Plaque PsoriasisCompletedNCT02515097Phase 3
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Revive Toric RWE StudyWithdrawnNCT06785194
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without AstigmatismCompletedNCT05264623Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisActive, not recruitingNCT03987763Phase 4
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work ProductivityActive, not recruitingNCT05132231
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- 1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for AstigmatismCompletedNCT05320042Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial ParticipantsCompletedNCT07717918Phase 1
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne VulgarisCompletedNCT07205107
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- 1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact LensesCompletedNCT06053736Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact LensesCompletedNCT05129488Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- 1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for PresbyopiaCompletedNCT05325931Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 LensesCompletedNCT04840563Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT07168902Phase 2
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye DiseaseCompletedNCT07128628Phase 2
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333015Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive AccuracyCompletedNCT06346340Phase 4
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Excimer Laser Trabeculostomy Glaucoma Treatment StudyCompletedNCT04899063Not applicable
Sponsor listed in the registry: Elios Vision, Inc. · First submitted before Elios Vision, Inc. became part of Bausch Health Companies Inc.
- Safety and Feasibility of the ELIOS System in POAG PatientsCompletedNCT05999006Not applicable
Sponsor listed in the registry: Elios Vision, Inc. · First submitted before Elios Vision, Inc. became part of Bausch Health Companies Inc.
- A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06594185Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular RednessCompletedNCT06803654Phase 3
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) LensTerminatedNCT06479148Not applicable
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- A Post-Market Clinical Follow-Up on Safety and Performance of the Ophthalmic Viscoelastic Devices Eyefill SC and Eyefill MBCompletedNCT06767917Not applicable
Sponsor listed in the registry: Bausch & Lomb GmbH · First submitted after Bausch & Lomb GmbH became part of Bausch Health Companies Inc.
- A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisCompletedNCT03988439Phase 4
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy VolunteersActive, not recruitingNCT06978244Phase 1
Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.
- Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT03596905Phase 2
Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.